In Vivo Pharmacodynamic Evaluation of B-Tg(Luc)HCT 116 (mix) Cells Induced Colorectal Cancer Models (CAT#: STEM-AE-0654-LGZ)

Introduction

Cancer type: Colorectal cancer
Cell line: B-Tg(Luc)HCT 116 (mix)
Clone: mix clone
Inoculation: Orthotopic

Principle Applications Procedure Materials Notes Related Products

Principle

By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.

Applications

Colorectal Cancer

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder

Other recommended products

In Vivo Pharmacodynamic Evaluation of B-hGRP Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0434-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hMUC1 Mice (Humanized Mice) (CAT#: STEM-AE-0638-LGZ)
In Vivo Pharmacodynamic Evaluation of SK-N-SH Cell Line Based Brain Cancer (CAT#: STEM-AE-0010-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hIL6/hIL6R Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0533-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hIL7R Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0187-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCD3E/hFAP Mice (Humanized Mice) (CAT#: STEM-AE-0604-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCD3EDG/hCD20 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0283-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hNKP46 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0313-LGZ)